2022
DOI: 10.21608/ejhm.2022.256313
|View full text |Cite
|
Sign up to set email alerts
|

One Anastomosis Gastric Bypass Versus Roux-En-Y Gastric Bypass: A New Limb Length Modification, is it Effective? A Prospective Cohort Study

Abstract: Introduction: Bariatric surgeries are effective in treating obesity and its associated co-morbidities. The ideal bariatric surgery with satisfactory weight or BMI loss and with few complications and nutritional deficiencies still does not exist. Modifications in one anastomosis gastric bypass (OAGB) and Roux-en-Y gastric bypass (RYGB) are still under study for best BMI loss with few complications. Objective: The aim of the current work was to compare both surgeries, OAGB and RYGB, after limb length modificatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…As far as we know, only three studies compared OAGB and long BPL RYGB. Two were retrospective [ 24 , 25 ], and only one was an RCT [ 26 ] to determine if morbid obesity patients can benefit from lengthening the BPL in RYGB. In the RCT, the authors changed the ratio of AL to BPL so that the BPL was longer (150 cm) than the AL (60 cm).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As far as we know, only three studies compared OAGB and long BPL RYGB. Two were retrospective [ 24 , 25 ], and only one was an RCT [ 26 ] to determine if morbid obesity patients can benefit from lengthening the BPL in RYGB. In the RCT, the authors changed the ratio of AL to BPL so that the BPL was longer (150 cm) than the AL (60 cm).…”
Section: Discussionmentioning
confidence: 99%
“…Fouly et al [ 25 ] stated that OAGB was superior to long BPL RYGB regarding BMI and excess weight loss at 3, 6, 12, and 24 months, with no differences regarding comorbidity resolution.…”
Section: Discussionmentioning
confidence: 99%